BD Oncomark™ CD4/CD25/CD3 - SFDA Registration ME0000002814SFDAA00177
Access comprehensive regulatory information for BD Oncomark™ CD4/CD25/CD3 in the Saudi Arabia medical device market through Pure Global AI's free database. This General IVD(Others) device is registered with Saudi Arabia SFDA under registration number ME0000002814SFDAA00177 and manufactured by Becton, Dickinson and Company, BD Biosciences.
This page provides complete registration details including product category (Chemicals), manufacturer information, model details, and regulatory compliance data from the official Saudi Arabia SFDA medical device database. Pure Global AI offers free access to Saudi Arabia's complete medical device registry, helping global MedTech companies navigate SFDA regulations efficiently.
Anti CD4/CD25/CD3 for flow cytometer
BD Oncomark™ CD4 FITC/CD25 PE/ CD3 PerCP-Cy™5.5* is intended for in vitro flow cytometric immunophenotyping of CD25 in normal and abnormal T cells.1-3 CD3+ T cells express the CD25 antigen after stimulation.4,5 T cells transformed by the human T-cell lymphotrophic virus also over-express CD25.6,7 Aberrant ratios of CD3+CD4+ and CD3+CD4– populations might develop in many T-cell disorders. CD4/CD25/CD3 assays are used in the diagnosis of hematologic disorders.
[]